Wow, you are so right! If I were you, I'd short it. If you short 5000 shares and the stock drops 50%, you will make over a quarter million dollars! How could you go wrong. (~:
Make sure you hold your shares in a cash account. Most brokerages automatically place your shares in a margin account (even if you paid cash). As a result they are able to lend your shares to short sellers. If you don't want your shares lent out, call your broker and tell them to place in a cash account.
Wonder if short selling is driving this down. Really low volume, but this stock is down 10+ % in the last 2 hours. Feels like manipulation to me...
What is your problem that you get pleasure from other people's pain? I don't own this (actually want to buy for the long term), but I've had stocks like this and it's no fun. I guess you've never been there. Or you totally lack empathy. Better to lose money than be a loser at life...
This stock needs a flush. Get all the weak hands out on high volume. This just keeps legging down... and will continue to do that until we get capitulation. 5 handle? 4 handle? Let's just get it over with.
Talk about loons. Look at science -- sperm are alive, as are eggs; not to mention cows, pigs, chickens, etc. which you likely eat (and are therefore responsible for their death). Consciousness does not begin at conception... viability does not exist at conception. You are imposing your moralistic and religious views on what Joe Biden said. Don't mistake that for science. And have some confidence in your beliefs. Allow your G*d to be the judge. Or don't you trust in them? These are personal decisions... not policy decisions...
I don't own this stock, but have been looking to get in at the right price. You sir, are a basher and a fear-monger. Citron, a legitimate entity, I believe had a downside price target around 60. In this terrible market, I anticipate a 5 handle... maybe even high 40s. But 22???? That would mean a forward P/E of 6 for a company growing 20+ percent YOY. That's crazy, basher talk. Anything can happen. If the Dow goes under 10K... if competition steals the GoPro account and revenues turn into losses. But you have not suggested any of these scenarios... just that Ambarella was overpriced. But it is not so overpriced now. Just caught in a very negative cycle. This is a good company with a bright future. I don't know your motivation, other than gloating over others misfortune, but it is not informative or helpful. Guessing you are going to rip me for this, but I suggest you think a bit more about your posts, and post with integrity. People who own AMBA are hurting, and you are just piling on. Good luck to all on their investments!
Enough with the conspiracy theories. This is a relatively expensive tech stock (basically a semiconductor co. -- which is an out of favor segment of the market). It is also up more than 100% this year, so people who are looking to preserve profits are selling, as well as traders, and hedge funds. This is a good company, but the stock could go a good bit lower if market conditions continue to deteriorate. I expect low 60s if not a 5 handle if the market continues to churn. If you are in for the long term, hang in... but if you have a profit, you might want to take some off the table.
Could have had $85+ this year. You are talking about a pretty far fetched possibility. The Perrigo deal is dilutive (not accretive until 2019 per MYL management) -- as a shareholder, I can't talk this stock up in good conscience. Coury is a bull in the China shop.
That is an irresponsible statement. This is a good company, but a bottom isn't put in in an hour. On Weds this dropped to 78 before rallying to 83. Then dropped to 73 yesterday... before dropping to 69 this morning and then rallying to 73. Until the market stabilizes, this may go a lot lower.
Going negative soon. This is a good company, but the market is week and support is broken. Look at charts of SNDK and MU and you see what happens to richly priced semis.
As a fellow shareholder, I hope you are right. Unfortunately, I have been down this path before and know what happens to ostriches that bury their head in the sand. The reality is that this company does not appear to have the capital or the means to acquire it, to ride this until the tech is "proven." There is zero cash flow. Likely, they will declare bankruptcy in the next year and debt holders will own this. Someone else will get rich off this, not current shareholders. At this share price, ETRM stock is really priced like an option... or a lottery ticket, so I will hold. But I fully expect to lose 100% of my investment. The odds of another outcome are slim. Just being realistic.
Mylan has acted arrogantly and without regard to shareholders... don't think they have given a lot of consideration to stakeholders either. The shareholders are in the highest risk position, and management has a fiduciary obligation to them. The tax conversion to an Irish company made all unrealized capital gains on this stock immediately realized. Now with the stock down $10 from there and plummeting, I am sitting on huge unrealized losses and a huge tax bill. This will continue to put downward pressure on the stock, which is now looking broken. I am waiting for the lawsuits. One of the good stock picks I made is now a train wreck. Management acted in their own interests. Bondholders were not in an equity position, and were not in a risk or reward position with regard to Mylan's decisions re: Conversion or acquisition... other than the fact that Mylan is now a more levered, less capitalized position, and has a significantly lower market cap. Oops... not sure this benefitted bond holders. What about employees? Well if the Perrigo deal goes through, Mylan will surely need to start cost cutting to achieve efficiencies. That means job cuts. In fact, the relocation to Ireland probably means some existing employees lost their jobs. Doesn't seem like Mylan is looking out for ANY stakeholders other than MANAGEMENT! How this looks in 5 years is open to debate... but it looks terrible here. Mylan acknowledges this deal will not be accretive until 2019... therefore it is dilutive. How does this benefit anyone but management. Comments?
A base does not form in 15 minutes. Shorts have made a fortune on this today. Anticipate another wave of selling. If you are in this for the long term... hang on. If you want to buy more, I'd wait. This is way to volatile. Don't know if it's going to 50 or 100... and am not prepared to gamble.
All sales by management are scheduled in advance... he did not have the option to sell more... or less... based on that days share price. Management can't trade on insider info. You are reading things into this sale that don't exist. Other than the fact that insiders are selling on a scheduled basis.
Stop living in the world of 2 months ago... Valuations have changed! Ambarella is still an expensive speculative stock (trades at PE of 40... other fast growing semi cos.. SWKS trading at half that). The quarter was good... but not great. Especially the guidance. Momentum players are bailing and Ambarella may end up with a 6 or 5 handle short term. I like this company long term, but the whole market valuation has changed, and China is suspect. Luck to all.
borrero.ernest is a short... clearly the market has priced this in the $6-8 range. demapples is a hyper... feels "fair value" is double where it is now. Yes we want a premium... but sounds like the Baxalta offer that Ariad rejected was at least 30-40% higher than where it was trading. Ariad management did shareholders a disservice (unless they know things they have not shared).
All the pie in the sky longs who think Ariad is a 10B company are dreaming. If management flat out rejected Shire's offer, they did shareholders a disservice. Wish they had negotiated. $12 would have been a good fair price for this company. While we are trading at 2011 levels, there is not the same level of promise there was back then. I do not believe other companies are interested in Ariad. Ever since the share price stabilized post crash last year, this stock has languished in the 6-8 range. If there was interest and real prospects, this stock would have performed - moved up - like the rest of the biotechs. Reality is Ariads drugs have a limited application and limited market. I bought it based on the prospects that the company once had... now I am just hoping to recoup some of my money. Foolish management still lacks perspective on their own products. I will sell on the next bounce... if there is one.